Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth in bioprocessing and a stable healthcare demand, though uncertainties regarding currency and tariffs could impact performance.
Analysis Date: February 6, 2025 Last Updated: May 29, 2025
+278%
+14.2% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryIE
ExchangeNYSE
IndustryMedical - Devices
SectorHealthcare
Market Cap$20.14B
CEOMr. Daniel A. Carestio
STERIS plc is a company that helps keep hospitals and healthcare facilities safe from infections. They provide cleaning products, tools, and equipment that help doctors and nurses perform their jobs effectively. STERIS also offers services to ensure that medical instruments are properly cleaned and sterilized. In addition to healthcare, they provide products for dental offices and support for companies that make medical devices and medicines.
Streams of revenue
Product:52%
Service:48%
Geographic Distribution
UNITED STATES:74%
Other foreign locations:25%
IRELAND:2%
Core Products
๐
Endoscopy ProductsEndoscopic devices
๐ช
Surgical SolutionsSurgical equipment
๐ฅ
Healthcare ServicesHealthcare support
๐ฆ
Infection PreventionInfection control
๐งผ
Sterilization ProductsMedical sterilizers
Business Type
Business to Business
Competitive Advantages
Unlock Competitive Advantages Analysis
Discover all competitive advantages and strategic moats that protect STE's market position.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
๐
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
๐
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
STE (STERIS plc) is a Healthcare company listed on New York Stock Exchange. The stock has generated 14.2% annual returns with an overall investment score of None/100.
Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth in bioprocessing and a stable healthcare demand, though uncertainties regarding currency and tariffs could impact performance.
STE Key Financial Metrics
STE financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 0.24290023659581383/100 and profitability score of 5.0/100 with financial health rated 8.05/100.
About STERIS plc
STERIS plc is a company that helps keep hospitals and healthcare facilities safe from infections. They provide cleaning products, tools, and equipment that help doctors and nurses perform their jobs effectively. STERIS also offers services to ensure that medical instruments are properly cleaned and sterilized. In addition to healthcare, they provide products for dental offices and support for companies that make medical devices and medicines.
STE Investment Recommendation
Based on our comprehensive analysis of STE, investors should consider the company's strong performance track record, earnings consistency (7/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
STE operates in the Medical - Devices industry within the Healthcare sector. This analysis compares STERIS plc performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about STE Stock
Is STE a good investment?
STE (STERIS plc) has generated 14.2% annual returns with an overall score of None/100. Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth โฆ Investors should consider their risk tolerance and investment goals when evaluating STE.
What is STE P/E ratio and valuation?
STE valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Devices industry and Healthcare sector benchmarks. The company currently has a valuation score of 0.24290023659581383/100.
Should I buy STE stock now?
The decision to buy STE stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 8.05/100, and detailed performance metrics to help inform your investment decision.
What are STE financial health indicators?
STE financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.05/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does STE compare to competitors?
STE performance is benchmarked against Medical - Devices industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for STERIS plc's market position.
What are STE historical returns?
STE has generated 14.2% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
STE Key Investment Metrics Summary
Annual Return: 14.2%
Valuation Score: 0.24290023659581383/100
Profitability Score: 5.0/100
Financial Health Score: 8.05/100
Growth Score: 3.0448106185896298/100
Earnings Beat Rate: 7/10 quarters
Sector: Healthcare
Industry: Medical - Devices
Exchange: New York Stock Exchange
Market Cap: 20137276273
STE Investment Thesis
STERIS plc (STE) represents a strong investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
Moderate Price-to-Sales Ratio
Healthy Gross Profit Margin
Strong Operating Profit Margin
Low Debt Levels
Strong Interest Coverage
Solid Current and Quick Ratios
Strong Revenue Growth
Improved Margins
Strong Backlog and Order Growth
Cautiously Optimistic Growth in Bioprocessing
Stable Healthcare Demand
Tightened Revenue Guidance
Investment Risks
High Price-to-Earnings Ratio
Elevated EV/EBITDA Ratio
Moderate Net Profit Margin
Low Cash Ratio
Legal and Regulatory Challenges
Capital Equipment Revenue Decline
Uncertainties due to Currency Fluctuations
Potential Impact of Tariffs
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.